Many Hospitalized COVID-19 Patients Are Given Antibiotics. That’s A Problem

As the Covid-19 pandemic continues into its second year, public health experts are increasingly concerned that the response to this global crisis may be accelerating another one: the development and persistence of the antibiotic-resistant bacteria known as superbugs. Why? All antibiotic use hastens the emergence of resistance. And although antibiotics aren’t used to treat Covid-19, which is a viral illness, they’re often prescribed to Covid-19 patients who are at risk for bacterial infection.

New research from our organization, The Pew Charitable Trusts, sheds additional light on the extent to which antibiotics are being prescribed unnecessarily in the midst of the pandemic. In a study of nearly 6,000 hospital admissions between February and July 2020 among patients with Covid-19, at least one course of antibiotics was given to more than half (52%) during their hospital stays.

That’s significantly greater than the percentage of those patients who had bacterial infections. In just 20% of admissions, patients were diagnosed with suspected or confirmed bacterial pneumonia, and only 9% were diagnosed with a community-acquired urinary tract infection. The actual number of cases of such bacterial infections is probably even lower based on the was the study was conducted.

This disparity between the number of patients treated with an antibiotic and those who actually needed one is at least partly explained by the fact that the vast majority of patients who received antibiotics were given their first course within 48 hours of admission — before medical personnel would typically know the result of diagnostic tests for bacterial infection.

Read the full piece on STAT (originally published March 30, 2021).

Person at hospital window
Person at hospital window
Issue Brief

Efforts Fighting the Coronavirus Overusing Antibiotics?

Quick View
Issue Brief

For years, leading public health and national security experts have sounded the alarm about the growing threat of antibiotic-resistant bacteria. The more antibiotics are used, the faster that bacteria evolve to resist them, giving rise to so-called “superbugs”—bacteria that are extremely difficult or impossible to treat with existing drugs.

Virus Outbreak-Reinfection
Virus Outbreak-Reinfection
Article

Antibiotic Stewardship Programs Are Vital During Crises

Quick View
Article

As coordinator of the University of Maryland Medical Center’s (UMMC) antibiotic stewardship program, infectious diseases pharmacist Emily Heil leads a team of medical professionals dedicated to combating the spread of antibiotic-resistant superbugs while optimizing patients’ antibiotic treatments.